(Q44326219)

2 December 2017

title

Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas? (English)

1 reference

2 December 2017

1 reference

Renata Santos Tourinho

1

1 reference

2 December 2017

Adilson José de Almeida

2

1 reference

2 December 2017

Luciane Almeida Amado

3

1 reference

2 December 2017

Livia Melo Villar

4

1 reference

2 December 2017

Ana Rita Coimbra Motta Castro

5

1 reference

2 December 2017

Vanessa Salete de Paula

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

19 August 2012

1 reference

2 December 2017

1 reference

2 December 2017

volume

30

1 reference

2 December 2017

issue

45

1 reference

2 December 2017

page(s)

6421-6426

1 reference

Hepatitis A shifting epidemiology in Latin America

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980-2002--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Who should receive hepatitis A vaccine?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Detection of HCV antibodies in oral fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Detection of hepatitis A antibodies by ELISA using saliva as clinical samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Simple and reliable salivary tests for HIV and hepatitis A and B virus diagnosis and surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Sensitivity of HIV antibody detection in saliva.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Modified enzyme immunoassay to detect hepatitis C virus antibodies in oral fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Efficiency of oral fluid collection devices in extracting antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.08.015

1 reference

2 December 2017

1 reference